What this study is
Objectives:
Primary Objective
To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
What's being tested
- CD34 Positive Stem Cell Infusion
Intervention · BIOLOGICAL
Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells.
- Miltenyi device
Intervention · DEVICE
Miltenyi device is used for CD34+ cell infusions) to patients who experience poor graft function after stem cell transplantation (SCT).
Study details
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Blood And Marrow Transplantation
- Enrolling
- 200 people
- Starts
- 2015-05-06
- Est. completion
- 2027-05-01
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients who have poor or no graft function post stem cell transplantation.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Texas MD Anderson Cancer Center
Houston, Texas, United States
Recruiting
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID 2015-0295
Principal investigator
Elizabeth Shpall, MD
M.D. Anderson Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.